Filing Details
- Accession Number:
- 0001437749-23-032410
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-11-17 09:11:44
- Reporting Period:
- 2023-11-16
- Accepted Time:
- 2023-11-17 09:11:44
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1625101 | Pulse Biosciences Inc. | PLSE | Surgical & Medical Instruments & Apparatus (3841) | 465696597 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1913245 | Patrick Kevin Danahy | C/O Pulse Biosciences, Inc. 3957 Point Eden Way Hayward CA 94545 | Chief Executive Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2023-11-16 | 4,781 | $6.52 | 35,275 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2023-11-16 | 600 | $6.51 | 35,875 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2023-11-16 | 12 | $6.50 | 35,887 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |